BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu G, Xu Y, Zhang H, Ruan Z, Zhang P, Wang Z, Gao H, Che X, Xia Q, Chen F. A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma. Bioengineered 2021;12:7805-19. [PMID: 34636718 DOI: 10.1080/21655979.2021.1976050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Wu D, Chen H, Yan L, Xiang Q, Li Q, Wang T. Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes. Front Genet 2023;14. [DOI: 10.3389/fgene.2023.1107294] [Reference Citation Analysis]
2 Zhao B, Gui L, Zhang Z, Xiang Y, Sun X, Fan J, Huang L. A New Necroptosis-Related lncRNA Signature Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma Patients.. [DOI: 10.21203/rs.3.rs-2488288/v1] [Reference Citation Analysis]
3 Ren J, Yang J, Na S, Wang Y, Zhang L, Wang J, Liu J. Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment. Front Immunol 2022;13:998653. [DOI: 10.3389/fimmu.2022.998653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Xu Y, Li H, Lan A, Wu Q, Tang Z, Shu D, Tan Z, Liu X, Liu Y, Liu S, Zheng M. Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2363043] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Xu Y, Jin Y, Gao S, Wang Y, Qu C, Wu Y, Ding N, Dai Y, Jiang L, Liu S, Pan J. Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/7204415] [Reference Citation Analysis]
6 Wang Z, Li J, Zhang P, Zhao L, Huang B, Xu Y, Wu G, Xia Q. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. Front Genet 2022;13:862210. [DOI: 10.3389/fgene.2022.862210] [Reference Citation Analysis]
7 Sun Y, Xu Y, Che X, Wu G. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma. Front Cell Dev Biol 2022;10:881490. [DOI: 10.3389/fcell.2022.881490] [Reference Citation Analysis]